Gene expression in blood of subjects with Duchenne muscular dystrophy

Neurogenetics

Volumn 10, Issue 2, 2009, Pages 117-125

  Wong, Brenda ^a   Gilbert, Donald L ^a   Walker, Wynn L ^b   Liao, Isaac H ^b   Lit, Lisa ^b   Stamova, Boryana ^b   Jickling, Glen ^b   Apperson, Michelle ^b   Sharp, Frank R ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood; Immune; Microarrays; Muscle; Muscular dystrophy

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLUSTER ANALYSIS; CONTROLLED STUDY; DEVICE; DUCHENNE MUSCULAR DYSTROPHY; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; STUDENT T TEST;

ADOLESCENT; CELL MOVEMENT; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES; MALE; MOLECULAR SEQUENCE DATA; MUSCULAR DYSTROPHY, DUCHENNE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; YOUNG ADULT;

EID: 64149118096     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-008-0167-8     Document Type: Article

References (29)

1. JG Tidball M Wehling-Henricks 2005 Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis Curr Opin Rheumatol 17 707 713
2. MJ Spencer JG Tidball 2001 Do immune cells promote the pathology of dystrophin-deficient myopathies? Neuromuscul Disord 11 556 564
3. RT Moxley 3rd S Ashwal S Pandya A Connolly J Florence K Mathews L Baumbach C McDonald M Sussman C Wade 2005 Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society Neurology 64 13 20
4. RC Griggs RT Moxley 3rd JR Mendell GM Fenichel MH Brooke A Pestronk JP Miller VA Cwik S Pandya J Robison 1993 Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months) Neurology 43 520 527
5. MB Bromberg JJ Wald DA Forshew EL Feldman JW Albers 1997 Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis J Neurol Sci 150 59 62
6. YW Chen P Zhao R Borup EP Hoffman 2000 Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology J Cell Biol 151 1321 1336
7. JN Haslett D Sanoudou AT Kho M Han RR Bennett IS Kohane AH Beggs LM Kunkel 2003 Gene expression profiling of Duchenne muscular dystrophy skeletal muscle Neurogenetics 4 163 171
8. R Raju MC Dalakas 2005 Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes Brain 128 1887 1896
9. Y Tang MB Schapiro DN Franz BJ Patterson FJ Hickey EK Schorry RJ Hopkin M Wylie T Narayan TA Glauser DL Gilbert AD Hershey FR Sharp 2004 Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome Ann Neurol 56 808 814
10. Y Tang H Xu X Du L Lit W Walker A Lu R Ran JP Gregg M Reilly A Pancioli JC Khoury LR Sauerbeck JA Carrozzella J Spilker J Clark KR Wagner EC Jauch DJ Chang P Verro JP Broderick FR Sharp 2006 Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study J Cereb Blood Flow Metab 26 1089 1102
11. WL Walker IH Liao DL Gilbert B Wong KS Pollard CE McCulloch L Lit FR Sharp 2008 Empirical Bayes accommodation of batch-effects in microarray data using identical replicate reference samples: application to RNA expression profiling of blood from Duchenne muscular dystrophy patients BMC Genomics 20 494 501
12. VG Tusher R Tibshirani G Chu 2001 Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci U S A 98 5116 5121
13. R Tibshirani T Hastie B Narasimhan G Chu 2002 Diagnosis of multiple cancer types by shrunken centroids of gene expression Proc Natl Acad Sci U S A 99 6567 6572
14. DE Ransohoff 2004 Rules of evidence for cancer molecular marker discovery and validation Nat Rev Cancer 4 309 314
15. J Shanmuga Sundaram V Mohana Rao AK Meena MP Anandaraj 2006 Altered expression, intracellular distribution and activity of lymphocyte calpain II in Duchenne muscular dystrophy Clin Chim Acta 373 82 87
16. RM McDouall MJ Dunn V Dubowitz 1990 Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy J Neurol Sci 99 199 217
17. E Gussoni GK Pavlath RG Miller MA Panzara M Powell HM Blau L Steinman 1994 Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy J Immunol 153 4798 4805
18. X Du Y Tang H Xu L Lit W Walker P Ashwood JP Gregg FR Sharp 2006 Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome Genomics 87 693 703
19. PT Golumbek RM Keeling AM Connolly 2007 Strength and corticosteroid responsiveness of mdx mice is unchanged by RAG2 gene knockout Neuromuscul Disord 17 376 384
20. A Gaud JM Simon T Witzel M Carre-Pierrat CG Wermuth L Segalat 2004 Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans Neuromuscul Disord 14 365 370
21. J Collins B Wong A McCullough J Quinlan 2006 The effects of prednisone on exercise-induced muscle damage in mdx mice Neuromuscul Disord 16 706
22. TA Rando 2001 The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies Muscle Nerve 24 1575 1594
23. KJ Langenbach TA Rando 2002 Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells Muscle Nerve 26 644 653
24. T Haenggi JM Fritschy 2006 Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue Cell Mol Life Sci 63 1614 1631
25. M Inoue Y Wakayama H Kojima S Shibuya T Jimi H Oniki I Nishino I Nonaka 2006 Expression of myoferlin in skeletal muscles of patients with dysferlinopathy Tohoku J Exp Med 209 109 116
26. RM Guzzo M Salih ED Moore BS Tuana 2005 Molecular properties of cardiac tail-anchored membrane protein SLMAP are consistent with structural role in arrangement of excitation-contraction coupling apparatus Am J Physiol Heart Circ Physiol 288 H1810 H1819
27. W Fu J Wei J Gu 2006 MEF2C mediates the activation induced cell death (AICD) of macrophages Cell Res 16 559 565
28. FL Robinson JE Dixon 2006 Myotubularin phosphatases: policing 3-phosphoinositides Trends Cell Biol 16 403 412
29. I Verde G Pahlke M Salanova G Zhang S Wang D Coletti J Onuffer SL Jin M Conti 2001 Myomegalin is a novel protein of the golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase J Biol Chem 276 11189 11198